MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AM211

CAS No. : 1175526-27-8

MCE 站：AM211

产品活性：AM211 是一种有效的，选择性的，可口服的前列腺素受体 (DP2) 拮抗剂，对人，小鼠，豚鼠和大鼠的 DP2 的 IC₅₀ 值分别为 4.9 nM，7.8 nM，4.9 nM，10.4 nM。

研究领域：GPCR/G Protein

作用靶点：Prostaglandin Receptor

In Vitro: AM211 is a potent, selective and orally bioavailable prostaglandin D2 (PGD2) receptor type 2 (DP2) antagonist, with IC₅₀s of 4.9 nM, 7.8 nM, 4.9 nM, 10.4 nM for human, mouse, guinea pig, and rat DP2, respectively. In the presence of 0.2% serum albumin, AM211 inhibits radiolabeled PGD2 binding to human, mouse, guinea pig, and rat DP2 with IC₅₀ values of 12.2, 20.1, 22.9, and 34.2 nM, respectively. AM211 displays high selectivity for DP2 versus other receptors in the prostanoid family, with IC₅₀ values for the inhibition of radioligand binding to human TP, IP, DP1, and FP of more than 100 μM. AM211 (100 μM) shows no activity at COX-1, COX-2 enzymes as well as PPAR family of nuclear receptors.

In Vivo: AM211 (1, 10, and 30 mg/kg, p.o.) dose-dependently decreases in the number of DK-PGD2-induced peripheral blood leukocytes, with a calculated ED₅₀ of 0.85 mg/kg. AM211 (30 mg/kg) also decreases antigen-induced pulmonary inflammation in guinea pigs. AM211 (10 mg/kg, p.o.) causes significant decrease in ovalbumin (OVA)-induced sneezing in a mouse model of allergic rhinitis.

相关产品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Endocrinology Compound Library  |  Orally Active Compound Library  |  Prostaglandin E2  |  Prostaglandin E1  |  Iloprost  |  PF-04418948  |  Tranilast  |  ONO-AE3-208  |  AH 6809  |  U-46619  |  Latanoprost  |  Laropiprant  |  Rebamipide  |  Travoprost  |  RO1138452  |  Ramatroban  |  p-Hydroxycinnamic acid  |  Bimatoprost  |  Pectolinarin  |  Taprenepag  |  Dinoprost tromethamine salt  |  (+)-Cloprostenol  |  Dazoxiben  |  Evatanepag  |  L-798106  |  Seratrodast  |  Nedocromil  |  Treprostinil  |  CAY10471 Racemate  |  Cloprostenol sodium salt  |  L 888607  |  AZ12672857

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。